Credit Suisse’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $3.49M | Sell |
|
|||||
|
2023
Q4 | $3.51M | Sell |
|
|||||
|
2023
Q3 | $4M | Sell |
|
|||||
|
2023
Q2 | $4.35M | Buy |
|
|||||
|
2023
Q1 | $2.48M | Sell |
|
|||||
|
2022
Q4 | $3.48M | Sell |
|
|||||
|
2022
Q3 | $2.75M | Buy |
|
|||||
|
2022
Q2 | $1.39M | Sell |
|
|||||
|
2022
Q1 | $1.91M | Sell |
|
|||||
|
2021
Q4 | $4.62M | Buy |
|
|||||
|
2021
Q3 | $3.25M | Buy |
|
|||||
|
2021
Q2 | $2.27M | Sell |
|
|||||
|
2021
Q1 | $2.2M | Buy |
|
|||||
|
2020
Q4 | $2.96M | Buy |
|
|||||
|
2020
Q3 | $1.6M | Sell |
|
|||||
|
2020
Q2 | $2.23M | Buy |
|
|||||
|
2020
Q1 | $928K | Sell |
|
|||||
|
2019
Q4 | $4.19M | Buy |
|
|||||
|
2019
Q3 | $371K | Sell |
|
|||||
|
2019
Q2 | $573K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $93K | Buy |
|